Patents Assigned to Vengenics Limited
  • Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
    Patent number: 7566566
    Abstract: The present invention provides polypeptides that bind cellular receptors for vascular endothelial growth factor polypeptides; polynucleotides encoding such polypeptides; compositions comprising the polypeptides and polynucleotides; and methods and uses involving the foregoing. Some polypeptides of the invention exhibit unique receptor binding profiles compared to known, naturally occurring vascular endothelial growth factors.
    Type: Grant
    Filed: August 28, 2007
    Date of Patent: July 28, 2009
    Assignee: Vengenics Limited
    Inventors: Kari Alitalo, Markku M. Jeltsch